The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CARIBOU BIOSCIENCES INC COM 142038108 10,174 674,196 SH   SOLE   674,196 0 0
ILLUMINA INC COM 452327109 6,542 17,196 SH   SOLE   17,196 0 0
ORIC PHARMACEUTICALS INC COM 68622P109 8,853 602,272 SH   SOLE   602,272 0 0
ROYALTY PHARMA PLC SHS CL A G7709Q104 106,824 2,680,644 SH   SOLE   2,680,644 0 0
VANECK ETF TRUST GOLD MINERS ETF 92189F106 23,654 738,500 SH   SOLE   738,500 0 0
Y-MABS THERAPEUTICS INC COM 984241109 3,099 191,176 SH   SOLE   191,176 0 0